EUPATI announced that its second workshop will take place on April 2, 2014 at the Hotel InterContinental Warszawa, Poland.
The European Patients’ Academy on Therapeutic Innovation (EUPATI) has announced that its second workshop, “Reaching a Public Audience on Medicines Development,” will take place on April 2, 2014 at the Hotel InterContinental Warszawa, Poland.
The workshop has been designed to draw on EUPATI’s social research work involving patients and citizens across Europe, as well as to hear views from patient advocates and the public and to provide details about successful examples of information sharing. Among the attendees are likely to be representatives from stakeholder groups that have a role in the medicines development process, including patients, industry, academia, ethics committees, regulators, and medical professionals.
According to the organizers, “Breakout sessions will be used for brainstorming on the best ways to inform patients and citizens about medicines research and development. We want each workshop delegate to advise us on how EUPATI can meet the information needs of the patient community and provide information appropriately. Throughout the workshop you will have many opportunities to voice your opinions and share your thoughts. We strongly encourage open and active dialogues in Warsaw!”
EUPATI is funded by the Innovative Medicines Initiative, and aims to provide scientifically reliable, objective, comprehensive information to patients on medicines research and development. It seeks to increase the capacities and capabilities of well-informed patients and patient organizations to be effective advocates and advisors in medicines research.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.